Xeomin 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FXUV9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,214
Award facts
- Contract value 100% obligated
- $25,214.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $25,214.28 for Xeomin 100 Unit Vials on January 22, 2026, with an ultimate completion date of February 12, 2026. This firm fixed-price contract represents a non-competitive delivery order issued without set-aside designation to the pharmaceutical distributor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major healthcare solutions provider specializing in pharmaceutical distribution and medical supply procurement for federal agencies.
This delivery order is issued under AmerisourceBergen's parent company Cencora's broader Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 prime vehicle that runs through December 2031 and serves military healthcare programs globally. The IDC enables delivery of a comprehensive range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This specific order for Xeomin—a botulinum toxin injection used in medical and aesthetic applications—reflects the extensive portfolio of pharmaceutical products available through this strategic contracting vehicle that supports military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FXUV9?
SPE2DR26FXUV9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FXUV9 worth?
The government has obligated $25,214 on SPE2DR26FXUV9.
Is contract SPE2DR26FXUV9 an order under another contract?
Yes. SPE2DR26FXUV9 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXUV9 competed?
The extent of competition for SPE2DR26FXUV9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award